SOPHIE is brought to you by Innovation Factory

The many hurdles Life Sciences startups must overcome to commercialize

ORIGINAL ARTICLE, Stefan Palios,, August 24, 2022

Alex Muggah has seen hundreds of life sciences and healthtech companies work to commercialize their innovations. As Director of the Synapse Life Science Consortium, a partnership of public- and private-sector institutions in Hamilton, Ontario and administrator of SOPHIE life sciences commercialization grants, Muggah likens his job to that of a concierge: connecting high-potential startups to funding, infrastructure, and relevant partners to enable the commercialization of health innovation.

A lot of fantastic innovations find their origins in lab environments, but a working experiment doesn’t easily translate to a commercialized product. Speaking with BetaKit, Muggah shared some common hurdles that life sciences startups face as they move from functioning ideas to marketable products.

To continue reading, CLICK HERE.

Share this article